Fibrocell Science Inc.
FCSC
FCSC was delisted on the 12th of December, 2019.
30 hedge funds and large institutions have $6.24M invested in Fibrocell Science Inc. in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 6 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
6% less funds holding
Funds holding: 32 → 30 (-2)
23% less capital invested
Capital invested by funds: $8.08M → $6.24M (-$1.84M)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$131K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$69.7K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$51.1K |
| 4 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
+$18.4K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$11.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$733K |
| 2 |
AC
Armistice Capital
New York
|
-$393K |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$287K |
| 4 |
FPF
FNY Partners Fund
New York
|
-$80K |
| 5 |
VF
Virtu Financial
New York
|
-$42.5K |
FCSC Hedge Fund Activity: Q1 2018 in Review
30 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q1 2018, worth a combined $6.24M — down 23% from $8.08M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of FCSC and 4 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 7 added.
The largest buyer was Point72 Asset Management, adding an estimated $131K. The largest seller was Sabby Management, exiting entirely with an estimated $733K sold.
- 30 institutional investors held Fibrocell Science Inc. (FCSC) as of Q1 2018, down from 32 in Q4 2017.
- Funds reported $6.24M of Fibrocell Science Inc. stock for Q1 2018, down 23% quarter-over-quarter.
- 4 funds opened new Fibrocell Science Inc. positions in Q1 2018 and 6 closed out, a net change of -2 holders.
- The largest Fibrocell Science Inc. buyer in Q1 2018 was Point72 Asset Management, an estimated $131K added.
- The largest Fibrocell Science Inc. seller in Q1 2018 was Sabby Management, an estimated $733K sold.
Based on aggregated 13F filings for Q1 2018.